Trial · NCT04088734
Adverse events54
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 54
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Neutropenia | Blood and lymphatic system disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Mixed deafness | Ear and labyrinth disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Cushingoid | Endocrine disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Constipation | Gastrointestinal disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Diarrhoea | Gastrointestinal disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Dysphagia | Gastrointestinal disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Nausea | Gastrointestinal disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 2 | 5 | |
| other | Vomiting | Gastrointestinal disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 4 | 5 | |
| other | Gait disturbance | General disorders | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Cellulitis | Infections and infestations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Oral candidiasis | Infections and infestations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Otitis media | Infections and infestations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Respiratory tract infection | Infections and infestations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Upper respiratory tract infection | Infections and infestations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Alanine aminotransferase increased | Investigations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 3 | 5 | |
| other | Amylase increased | Investigations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Aspartate aminotransferase increased | Investigations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 5 | 5 | |
| other | Blood creatine phosphokinase increased | Investigations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 | |
| other | Blood lactate dehydrogenase increased | Investigations | scAAV9.U1a.hSGSH, 3x1013 vg/kg | 1 | 5 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04088734/events